Cargando…

Evaluation of tests to predict metallo-β-lactamase in cystic fibrosis (CF) and non-(CF) Pseudomonas

Double disks synergy test (DDST) and combined disks test (CD) were evaluated to predict the presence of metallo-β-lactamase in 70 Pseudomonas aeruginosa isolates recovered from cystic fibrosis and non-cystic fibrosis patients. DDST(CAZ-EDTA 1 cm) and CD(IMP-EDTA) tests showed the best accuracy (94.3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez, Leandro Reus Rodrigues, Limberger, Mariana Fagundes, Costi, Ricardo, Dias, Cícero Armídio Gomes, Barth, Afonso Luís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Microbiologia 2014
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204966/ https://www.ncbi.nlm.nih.gov/pubmed/25477915

Ejemplares similares

Improving the care of patients with cystic fibrosis (CF)
por: Khan, Ahsan Aftab, et al.
Publicado: (2017)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

68 Respiratory viral detection in children with cystic fibrosis (CF)
por: Tješić-Drinković, I., et al.
Publicado: (2015)

Demographic characteristics, clinical and laboratory features, and the distribution of pathogenic variants in the CFTR gene in the Cypriot cystic fibrosis (CF) population demonstrate the utility of a national CF patient registry
por: Yiallouros, Panayiotis K., et al.
Publicado: (2021)

Rehabilitation Programs for Cystic Fibrosis – View from a CF Center
por: Griese, M, et al.
Publicado: (2010)

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas
por: Evans, Ieuan E. S., et al.
Publicado: (2023)

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry
por: Vongthilath, Réchana, et al.
Publicado: (2019)

2151. Biofilm and Metallo-β-Lactamase (MBL) Production Among Imipenem-Resistant Pseudomonas aeruginosa and Acinetobacter spp.
por: Metok, Yang, et al.
Publicado: (2019)

Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis
por: De, Hriday, et al.
Publicado: (2016)

1481. Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
por: Edwards, Brett, et al.
Publicado: (2018)

Oral Hygiene and Periodontal Treatment Needs in Adult Patients with Cystic Fibrosis (CF)
por: Hildebrandt, Tomasz, et al.
Publicado: (2022)

INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW
por: Gramegna, Andrea, et al.
Publicado: (2018)

Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
por: Hewer, Simon C Langton, et al.
Publicado: (2020)

Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology
por: Barone, Simona, et al.
Publicado: (2022)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
por: Steinke, Eva, et al.
Publicado: (2023)

Theoretical insight into OH- and Cl-initiated oxidation of CF(3)OCH(CF(3))(2) and CF(3)OCF(2)CF(2)H & fate of CF(3)OC(X•)(CF(3))(2) and CF(3)OCF(2)CF(2)X• radicals (X=O, O(2))
por: Bai, Feng-Yang, et al.
Publicado: (2017)

Improving health literacy of antibiotic use in people with cystic fibrosis (CF)—comparison of the readability of patient information leaflets (PILs) from the EU, USA and UK of 23 CF-related antibiotics used in the treatment of CF respiratory infections
por: Tang, Ka Wah Kelly, et al.
Publicado: (2023)

Early detection of Pseudomonas aeruginosa – comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)
por: Xu, Jiru, et al.
Publicado: (2004)

Fermentation products in the cystic fibrosis airways induce aggregation and dormancy-associated expression profiles in a CF clinical isolate of Pseudomonas aeruginosa
por: Phan, Joann, et al.
Publicado: (2018)

1107. Three Year Longitudinal Assessment of Pseudomonas aeruginosa (Pa) Antibiotic Susceptibility in Children with Cystic Fibrosis (CF) in the Era of Modulator Therapy
por: Bradley, John, et al.
Publicado: (2023)

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial
por: Ronchetti, Katherine, et al.
Publicado: (2018)

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis
por: Schäfer, Jürgen, et al.
Publicado: (2018)

Draft Genome Sequence of Triclosan-Resistant Cystic Fibrosis Isolate Achromobacter xylosoxidans CF304
por: Jeukens, Julie, et al.
Publicado: (2015)

1257. Assessing Risk Factors for an Outbreak of Burkholderia cenocepacia in Non-cystic Fibrosis (CF) Patients
por: Hill-Ricciuti, Alexandra, et al.
Publicado: (2018)

Development and validation of the Cystic Fibrosis Decisional Balance for Physical Activity scale (CF-DB-PA)
por: Filleul, Valentine, et al.
Publicado: (2021)

The Microbiology of Non-aeruginosa Pseudomonas Isolated From Adults With Cystic Fibrosis: Criteria to Help Determine the Clinical Significance of Non-aeruginosa Pseudomonas in CF Lung Pathology
por: Moore, John E., et al.
Publicado: (2022)

Does Pseudomonas aeruginosa Colonization Affect Exercise Capacity in CF?
por: Kampouras, Asterios, et al.
Publicado: (2019)

1602. Comparative Activity of Ceftolozane-Tazobactam (C/T) and Ceftazidime-Avibactam (CZA) against Pseudomonas aeruginosa (PSA) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

492: CF innate immune defect affects CF intestinal microbiota
por: Scull, C., et al.
Publicado: (2021)

Trifluoromethyl Thianthrenium Triflate: A Readily Available Trifluoromethylating Reagent with Formal CF(3)(+), CF(3)(•), and CF(3)(–) Reactivity
por: Jia, Hao, et al.
Publicado: (2021)

Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections
por: Heirali, Alya, et al.
Publicado: (2016)

Connexin 37 and Connexin 43 genotypes in correlation to cytokines in induced sputum and blood in cystic fibrosis (CF)
por: Ludwig, M, et al.
Publicado: (2014)

The first report of Methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF) patients in Saudi Arabia
por: Banjar, Hanaa, et al.
Publicado: (2020)

N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review
por: Guerini, Marta, et al.
Publicado: (2022)

Patient engagement in the development of CF-CBT: A cystic fibrosis-specific cognitive-behavioral intervention for adults
por: Friedman, Deborah, et al.
Publicado: (2022)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

The Pros and Cons of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing Pulmonaria officinalis L. Extract: the Evidence from an In Vitro Study on Staphylococcus aureus CF Clinical Isolates
por: Sadowska, Beata, et al.
Publicado: (2019)

Gene therapy for CF.
por: Eubanks, M
Publicado: (2001)

TACKLING ANTIMICROBIAL RESISTANCE (AMR) - IN VITRO EFFECT OF SODIUM CHLORIDE ON ANTIBIOTIC SUSCEPTIBILITY IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS (CF)
por: Gramegna, Andrea, et al.
Publicado: (2020)

13. Evaluation of Etest for Antibiotic Susceptibility and Minimum Inhibitory Concentration (MIC) Agreement Against pseudomonas Aeruginosa (psa) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fdv678s2adelhn66m8k7ep0j82